Cargando…

Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes

Cancer registries have proven valuable with respect to validating therapeutic safety and drug efficacy, uncovering real-world implementation practices, and their evolution over time. Modern cancer therapeutics are approved as single agents oftentimes compared to the least active approved standard ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Michael K, Kaufman, Howard L, Daniels, Gregory A, McDermott, David F, Aung, Sandra, Lowder, James N, Morse, Michael A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100489/ https://www.ncbi.nlm.nih.gov/pubmed/25031835 http://dx.doi.org/10.1186/2051-1426-2-20

Ejemplares similares

The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)
por: Kaufman, Howard L., et al.
Publicado: (2014)

High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates
por: Wong, Michael K, et al.
Publicado: (2013)

Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
por: Kaufman, Howard L, et al.
Publicado: (2014)

Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2)
por: Clark, Joseph I, et al.
Publicado: (2015)

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIM(SM) registry
por: Curti, Brendan, et al.
Publicado: (2017)

Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma
por: Chandar, Ashwin, et al.
Publicado: (2015)

Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2
por: Wong, Michael KK, et al.
Publicado: (2015)

Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
por: Alva, Ajjai, et al.
Publicado: (2016)

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
por: Buchbinder, Elizabeth I., et al.
Publicado: (2016)

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM(SM) registry
por: Fishman, M., et al.
Publicado: (2019)

PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers
por: Zablotska, Iryna, et al.
Publicado: (2016)

Establishment of the National Brain Tumor Registry of China
por: Zhang, Liwei, et al.
Publicado: (2020)

Effects of microRNA-146a on the proliferation and apoptosis of human osteochondrocytes by targeting TRAF6 through the NF- κB signalling pathway
por: West, Camilla, et al.
Publicado: (2017)

Considerations for the development and implementation of electronic immunization registries in Africa
por: Namageyo-Funa, Apophia, et al.
Publicado: (2018)

Pharmacovigilance strategy: opportunities for cross-national learning
por: Fermont, Irene
Publicado: (2019)

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
por: Dutcher, Janice P, et al.
Publicado: (2014)

Towards creation of national cerebral palsy registries in Arab countries: what is missing?
por: Hassanein, Sahar M. A., et al.
Publicado: (2022)

Strengths, challenges and opportunities of implementing primary eye care in Nigeria
por: Aghaji, Ada E, et al.
Publicado: (2018)

Making implementation science more efficient: capitalizing on opportunities beyond the field
por: Wensing, Michel, et al.
Publicado: (2023)

National Trauma Registries in LMICs: Long-Overdue Priority: Comment on "Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries"
por: Asfaw, Zerubabbel K.
Publicado: (2023)

Suspension of the National Registry of Evidence-Based Programs and Practices: the importance of adhering to the evidence
por: Green-Hennessy, Sharon
Publicado: (2018)

Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry
por: Efficace, Fabio, et al.
Publicado: (2014)

A Practice Based Behavioral Health Management Registry (BHMR): Implementation, Structure and Content
por: Langley, Paul C
Publicado: (2019)

Opportunities and challenges for verbal autopsy in the national Death Registration System in Sri Lanka: past and future
por: Dharmaratne, Samath D, et al.
Publicado: (2011)

Challenges and Opportunities in Pharmacogenomics and Therapeutics
por: Kane, Michael D., et al.
Publicado: (2007)

Lessons from implementing the Australian National Action Plan for Endometriosis
por: Armour, Mike, et al.
Publicado: (2022)

Pharmacy practice in Qatar: challenges and opportunities
por: Kheir, Nadir, et al.
Publicado: (2011)

National Neurotrauma Registry Data in Low- and Middle-Income Countries – Current Status and Future Requirements: Comment on "Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries"
por: Lecky, Fiona
Publicado: (2023)

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
por: Widjaja, Anissa A., et al.
Publicado: (2020)

COVID-19: Clinching the Climate Opportunity
por: Stoll, Christian, et al.
Publicado: (2020)

National Medical School Matching Program: optimizing outcomes
por: Eltorai, Adam EM, et al.
Publicado: (2016)

Mental health near miss indicators in maternity care: a missed opportunity? A commentary
por: Easter, A, et al.
Publicado: (2017)

Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
por: Akel, Marwan, et al.
Publicado: (2022)

Global Neurotrauma Surveillance: Are National Databases Overrated?: Comment on "Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries"
por: Boeck, Marissa A., et al.
Publicado: (2022)

Neurotrauma Registries in Low- and Middle-Income Countries for Building Organized Neurotrauma Care: The LATINO Registry Experience: Comment on "Neurotrauma Surveillance in National Registries of Low- and Middle-Income Countries: A Scoping Review and Comparative Analysis of Data Dictionaries"
por: Rubiano, Andrés M., et al.
Publicado: (2022)

Unleashing implementation research to accelerate national noncommunicable disease responses
por: Collins, Tea, et al.
Publicado: (2022)

Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases
por: Waldmann, Thomas A
Publicado: (2004)

What are the Facilitators and Obstacles to Participation in Workplace Team Sport? A Qualitative Study
por: Brinkley, Andrew, et al.
Publicado: (2017)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
por: Prasanna, Pataje G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aq0v31lgq6o8kdc2ou2v9si1vq